Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

NCT02679079 is registered in ClinicalTrials.gov with Neurocrine Biosciences as lead sponsor.

NCT NCT02679079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
Lead sponsor
Neurocrine Biosciences
Phase
Phase 2
Overall status
Completed
Start date
March 23, 2016
Completion date
April 14, 2017
Enrollment
98 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

tourette syndrome